Use of bosentan for digital ulcers related to systemic sclerosis: a real-life retrospective French study of 89 patients treated since specific approval
C. Agard(Centre National de la Recherche Scientifique), É. Hachulla(Centre Hospitalier Universitaire de Lille), Luc Mouthon(Université Paris Cité), Virginie Gressin, A. Bérezné(Université Paris Cité), A. Sparsa(Centre Hospitalier Universitaire de Limoges), P. Jégo(CIC Rennes), I. Quéré(Centre Hospitalier Universitaire de Montpellier), Emmanuel Chatelus(Laboratoire National de Référence), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Patrick Carpentier(Université Grenoble Alpes), C. Lok(Centre Hospitalier Universitaire Amiens-Picardie), Élisabeth Diot(Centre Hospitalier Universitaire de Tours), A. Khau Van Kien(Hôpital Saint Eloi), Pierre Clerson
Cited by 16
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
|New England Journal of Medicine|2009|857
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699